AVENUE THERAPEUTICS, INC. (ATXI) has 29 open-market insider trades by 9 insiders since 2017. The most active filer is Neil Herskowitz, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| InvaGen Pharmaceuticals, Inc. | 10% Owner | — | 1 | $6.0M | 2022-10-11 |
| Fortress Biotech, Inc. | 10% Owner | — | 1 | $603K | 2026-01-02 |
| Lindsay A. Rosenwald M.D. | Dir | — | 3 | $585K | 2023-09-08 |
| Neil Herskowitz | Dir | — | 14 | $372K | 2024-12-02 |
| Jeffrey Paley | Dir | — | 1 | $133K | 2018-12-10 |
| Joseph Walter Vazzano | CFO | — | 5 | $122K | 2021-12-17 |
| Elizabeth Garrett Ingram | Dir | — | 1 | $100K | 2019-09-12 |
| Robert L. Davidow | 10% | — | 1 | $87K | 2023-12-11 |
| Jay D. Kranzler | Dir | — | 2 | $1K | 2024-11-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Neil Herskowitz | Director | Sell | $46 | 2024-12-02 |
| Jay D. Kranzler | Director | Sell | $137 | 2024-11-05 |
| Jay D. Kranzler | Director | Buy | $1K | 2024-09-27 |
| Robert L. Davidow | 10% | Sell | $87K | 2023-12-11 |
| Lindsay A. Rosenwald M.D. | Director | Buy | $251K | 2023-09-08 |
| Fortress Biotech, Inc. | 10% Owner | Buy | $603K | 2023-09-08 |
Companies that share insiders with ATXI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| InvaGen Pharmaceuticals, Inc. | 10% Owner | Sell | $6.0M | 2022-10-11 |
| Joseph Walter Vazzano | CFO | Sell | $12K | 2021-09-15 |
| Neil Herskowitz | Director | Buy | $10K | 2021-05-06 |
| Joseph Walter Vazzano | CFO | Sell | $47K | 2020-08-20 |
| Joseph Walter Vazzano | CFO | Buy | $27K | 2020-03-09 |
| Neil Herskowitz | Director | Buy | $21K | 2020-02-26 |
| Neil Herskowitz | Director | Buy | $93K | 2020-02-25 |
| Joseph Walter Vazzano | CFO | Buy | $11K | 2020-02-25 |
| Elizabeth Garrett Ingram | Director | Buy | $100K | 2019-09-12 |